Ignoring the modeling approaches: Towards the shadowy paths in nanomedicine
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Abstract Limited efficiency of the conventional therapeutic options against a variety of diseases has provoked nanotech‐based research efforts to develop advanced materials and devices for targeted delivery of theranostics which may provide imminent breakthroughs in medicine. However, nonspecific distribution or inappropriate tissue penetration of nanoparticles, complexity of drug delivery process, insufficient drug accumulation, loss of targeting ability, occurrence of the unexpected phenomena, safety concerns, and data reliability have remained challenging. Indeed, translation of nanotechnology‐based products to the clinical applications necessitates the rigorous consideration of the challenging issues associated with currently available nanoformulations. Computational models and simulations which enable to design the nanoparticles with optimized properties along with method validation, provide fundamental knowledge about the complex interaction of nanomaterials with environmental or biological systems, and predict the pharmacological profile of nanomaterials, should constitute a key part of the innovative drug delivery research leading to the maximal efficacy and minimal safety concerns. This review highlights the importance of computational modeling in the development of efficient nanotherapeutic delivery systems. Graphical abstract Figure. No caption available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609
Reproducible research in computational science
Peng, R. D. (2011) · Science · doi:10.1126/science.1213847 · Cited by 1,449
Challenges in Development of Nanoparticle-Based Therapeutics
Desai, N. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9339-4 · Cited by 1,173
Modalities, Modes, and Models in Functional Neuroimaging
Friston, K. J. (2009) · Science · doi:10.1126/science.1174521 · Cited by 489
Organ-on-a-chip platforms for studying drug delivery systems
Bhise, N. S., Ribas, J., Manoharan, V., Zhang, Y. S., Polini, A., Massa, S., Dokmeci, M. R., & Khademhosseini, A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.004 · Cited by 381
A Review of In Vitro Drug Release Test Methods for Nano-Sized Dosage Forms
D’Souza, S. (2014) · Advances in Pharmaceutics · doi:10.1155/2014/304757 · Cited by 262
Liposome imaging agents in personalized medicine
Petersen, A. L., Hansen, A. E., Gabizon, A., & Andresen, T. L. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.003 · Cited by 164
Loverde, S. M., Klein, M. L., & Discher, D. E. (2012) · Advanced Materials · doi:10.1002/adma.201103192 · Cited by 162
Berchane, N. S., Carson, K. H., Rice-Ficht, A. C., & Andrews, M. J. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.037 · Cited by 108
Cited by
Alshawwa, S. Z., Kassem, A. A., Farid, R. M., Mostafa, S. K., & Labib, G. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040883 · Cited by 531
Engineered strategies to enhance tumor penetration of drug-loaded nanoparticles
Souri, M., Soltani, M., Moradi Kashkooli, F., & Kiani Shahvandi, M. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.024 · Cited by 178
Nexus between in silico and in vivo models to enhance clinical translation of nanomedicine
Moradi Kashkooli, F., Soltani, M., Souri, M., Meaney, C., & Kohandel, M. (2021) · Nano Today · doi:10.1016/j.nantod.2020.101057 · Cited by 120
Improving nanotherapy delivery and action through image-guided systems pharmacology
Ng, T. S. C., Garlin, M. A., Weissleder, R., & Miller, M. A. (2020) · Theranostics · doi:10.7150/thno.37215 · Cited by 60
Computational Approaches in Theranostics: Mining and Predicting Cancer Data
Cova, T. F. G. G., Bento, D. J., & Nunes, S. C. C. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11030119 · Cited by 32
Metadata
- Authors
- Hassanzadeh, P., Atyabi, F., & Dinarvand, R.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 280
- Pages
- 58-75
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2799676273
- Cited by
- 34
- References
- 9
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ignoring the modeling approaches: Towards the shadowy paths in nanomedicine. https://app.cochat.ai/papers/10.1016/j.jconrel.2018.04.042
- The paper
- Hassanzadeh, P., Atyabi, F., & Dinarvand, R. (2018). Ignoring the modeling approaches: Towards the shadowy paths in nanomedicine. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2018.04.042
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.